• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲冠心病患者戒烟。来自欧洲心脏病学会 EUROASPIRE IV 调查的结果:一个注册研究。

Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: A registry from the European Society of Cardiology.

机构信息

ACHIEVE Centre of Applied Research, Faculty of Health, Amsterdam University of Applied Sciences, Amsterdam, the Netherlands.

Department of Cardiology, Thoraxcenter, Erasmus Medical Centre, Rotterdam, the Netherlands.

出版信息

Int J Cardiol. 2018 May 1;258:1-6. doi: 10.1016/j.ijcard.2018.01.064.

DOI:10.1016/j.ijcard.2018.01.064
PMID:29544918
Abstract

OBJECTIVE

We investigated smoking cessation rates in coronary heart disease (CHD) patients throughout Europe; current and as compared to earlier EUROASPIRE surveys, and we studied characteristics of successful quitters.

METHODS

Analyses were done on 7998 patients from the EUROASPIRE-IV survey admitted for myocardial infarction, unstable angina and coronary revascularisation. Self-reported smoking status was validated by measuring carbon monoxide in exhaled air.

RESULTS

Thirty-one percent of the patients reported being a smoker in the month preceding hospital admission for the recruiting event, varying from 15% in centres from Finland to 57% from centres in Cyprus. Smoking rates at the interview were also highly variable, ranging from 7% to 28%. The proportion of successful quitters was relatively low in centres with a low number of pre- event smokers. Overall, successful smoking cessation was associated with increasing age (OR 1.50; 95% CI 1.09-2.06) and higher levels of education (OR 1.38; 95% CI 1.08-1.75). Successful quitters more frequently reported that they had been advised (56% vs. 47%, p < .001) and to attend (81% vs. 75%, p < .01) a cardiac rehabilitation programme.

CONCLUSION

Our study shows wide variation in cessation rates in a large contemporary European survey of CHD patients. Therefore, smoking cessation rates in patients with a CHD event should be interpreted in the light of pre-event smoking prevalence, and caution is needed when comparing cessation rates across Europe. Furthermore, we found that successful quitters reported more actions to make healthy lifestyle changes, including participating in a cardiac rehabilitation programme, as compared with persistent smokers.

摘要

目的

我们调查了整个欧洲冠心病(CHD)患者的戒烟率;当前戒烟率与早期 EUROASPIRE 调查相比,同时研究了成功戒烟者的特征。

方法

对 EUROASPIRE-IV 调查中因心肌梗死、不稳定型心绞痛和冠状动脉血运重建而住院的 7998 例患者进行了分析。通过测量呼出空气中的一氧化碳来验证自我报告的吸烟状况。

结果

31%的患者报告在因招募事件住院前一个月吸烟,芬兰中心的吸烟率为 15%,塞浦路斯中心的吸烟率为 57%。在采访时,吸烟率也存在很大差异,范围从 7%到 28%。在事件前吸烟人数较少的中心,成功戒烟者的比例相对较低。总的来说,成功戒烟与年龄增加(OR 1.50;95%CI 1.09-2.06)和教育程度提高(OR 1.38;95%CI 1.08-1.75)相关。成功戒烟者更常报告他们接受过戒烟建议(56%比 47%,p < 0.001)和参加过心脏康复计划(81%比 75%,p < 0.01)。

结论

我们的研究表明,在一项针对欧洲 CHD 患者的大型当代调查中,戒烟率存在广泛差异。因此,在考虑 CHD 事件前的吸烟流行率的情况下,应解释患者的戒烟率,并且在比较整个欧洲的戒烟率时需要谨慎。此外,我们发现与持续吸烟者相比,成功戒烟者报告采取了更多的行动来改变健康的生活方式,包括参加心脏康复计划。

相似文献

1
Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey: A registry from the European Society of Cardiology.欧洲冠心病患者戒烟。来自欧洲心脏病学会 EUROASPIRE IV 调查的结果:一个注册研究。
Int J Cardiol. 2018 May 1;258:1-6. doi: 10.1016/j.ijcard.2018.01.064.
2
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.欧洲动脉粥样硬化调查项目IV:欧洲心脏病学会对来自24个欧洲国家的冠心病患者的生活方式、危险因素及治疗管理情况的调查。
Eur J Prev Cardiol. 2016 Apr;23(6):636-48. doi: 10.1177/2047487315569401. Epub 2015 Feb 16.
3
Factors associated with smoking cessation in patients with coronary heart disease: a cohort analysis of the German subset of EuroAspire IV survey.与冠心病患者戒烟相关的因素:EuroAspire IV 调查德国亚组的队列分析。
BMC Cardiovasc Disord. 2020 Mar 30;20(1):152. doi: 10.1186/s12872-020-01429-w.
4
Readiness for smoking cessation in coronary heart disease patients across Europe: Results from the EUROASPIRE III survey.欧洲冠心病患者戒烟准备度:来自 EUROASPIRE III 调查的结果。
Eur J Prev Cardiol. 2015 Sep;22(9):1212-9. doi: 10.1177/2047487314564728. Epub 2014 Dec 16.
5
Passive smoking and smoking cessation among patients with coronary heart disease across Europe: results from the EUROASPIRE III survey.欧洲冠心病患者中的被动吸烟和戒烟情况:来自 EUROASPIRE III 调查的结果。
Eur Heart J. 2014 Mar;35(9):590-8. doi: 10.1093/eurheartj/eht538. Epub 2013 Dec 13.
6
Smoking behaviour in European patients with established coronary heart disease.欧洲确诊冠心病患者的吸烟行为
Eur Heart J. 2006 Jan;27(1):35-41. doi: 10.1093/eurheartj/ehi497. Epub 2005 Oct 6.
7
Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey.冠心病患者心脏康复的应用和效果:来自 EUROASPIRE III 调查的结果。
Eur J Prev Cardiol. 2013 Oct;20(5):817-26. doi: 10.1177/2047487312449591. Epub 2012 Jun 19.
8
Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.欧洲冠心病患者生活方式、风险因素控制和循证药物使用的时间趋势:来自 3 项 EUROASPIRE 调查的结果,1999-2013 年。
Glob Heart. 2017 Dec;12(4):315-322.e3. doi: 10.1016/j.gheart.2015.11.003. Epub 2016 Mar 16.
9
Determinants of participation and risk factor control according to attendance in cardiac rehabilitation programmes in coronary patients in Europe: EUROASPIRE IV survey.依据欧洲冠心病患者参加心脏康复项目的情况评估其参与度和危险因素控制情况的决定因素:EUROASPIRE IV 调查。
Eur J Prev Cardiol. 2018 Aug;25(12):1242-1251. doi: 10.1177/2047487318781359. Epub 2018 Jun 6.
10
Smoking prevalence in coronary patients from EuroAspire III Romania.罗马尼亚EuroAspire III研究中冠心病患者的吸烟率
Pneumologia. 2009 Jul-Sep;58(3):190-4.

引用本文的文献

1
Assessment of smoking cessation outcomes in patients with cardiovascular disease: A retrospective cohort study from Türkiye.心血管疾病患者戒烟结果评估:一项来自土耳其的回顾性队列研究。
Tob Induc Dis. 2025 May 19;23. doi: 10.18332/tid/203867. eCollection 2025.
2
Efficacy of a Mobile Health App (eMOTIVA) Regarding Compliance With Cardiac Rehabilitation Guidelines in Patients With Coronary Artery Disease: Randomized Controlled Clinical Trial.移动健康应用 (eMOTIVA) 对冠心病患者遵循心脏康复指南的效果:随机对照临床试验。
JMIR Mhealth Uhealth. 2024 Jul 25;12:e55421. doi: 10.2196/55421.
3
Smoking behaviour in post-acute myocardial infarction patients: cross-sectional study.
急性心肌梗死后患者的吸烟行为:横断面研究。
Ann Med Surg (Lond). 2024 Apr 3;86(5):2531-2537. doi: 10.1097/MS9.0000000000001333. eCollection 2024 May.
4
Correlation Analysis Between Required Surgical Indexes and Complications in Patients With Coronary Heart Disease.冠心病患者手术所需指标与并发症的相关性分析
Front Surg. 2022 Jul 6;9:948666. doi: 10.3389/fsurg.2022.948666. eCollection 2022.
5
Improving smoking cessation after myocardial infarction by systematically implementing evidence-based treatment methods.通过系统实施基于证据的治疗方法来提高心肌梗死后的戒烟率。
Sci Rep. 2022 Jan 12;12(1):642. doi: 10.1038/s41598-021-04634-5.
6
Lifestyle management to prevent atherosclerotic cardiovascular disease: evidence and challenges.预防动脉粥样硬化性心血管疾病的生活方式管理:证据与挑战
Neth Heart J. 2022 Jan;30(1):3-14. doi: 10.1007/s12471-021-01642-y. Epub 2021 Nov 11.
7
Active Ingredients and Mechanisms of Change in Motivational Interviewing for Smoking Cessation in Patients With Coronary Artery Disease: A Mixed Methods Study.冠心病患者戒烟动机性访谈的活性成分及改变机制:一项混合方法研究
Front Psychol. 2021 Jun 22;12:599203. doi: 10.3389/fpsyg.2021.599203. eCollection 2021.
8
Is Weight Gain Inevitable for Patients Trying to Quit Smoking as Part of Cardiac Rehabilitation?戒烟作为心脏康复的一部分,患者体重增加是否不可避免?
Int J Environ Res Public Health. 2020 Nov 18;17(22):8565. doi: 10.3390/ijerph17228565.
9
Determinants of persistent smoking after acute myocardial infarction: an observational study.急性心肌梗死后持续吸烟的决定因素:一项观察性研究。
BMC Cardiovasc Disord. 2020 Aug 24;20(1):384. doi: 10.1186/s12872-020-01641-8.
10
The scientific basis for secondary prevention of coronary artery disease: recent contributions from the Netherlands.冠状动脉疾病二级预防的科学依据:荷兰的最新贡献。
Neth Heart J. 2020 Aug;28(Suppl 1):136-140. doi: 10.1007/s12471-020-01450-w.